Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Palmer, Nicholette D ^a   Ng, Maggie C Y ^a   Hicks, Pamela J ^a   Mudgal, Poorva ^a   Langefeld, Carl D ^a   Freedman, Barry I ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIN;

ADULT; AFRICAN AMERICAN; AGTR1 GENE; APOL1 GENE; ARTICLE; CHN2 GENE; CNDP1 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ENVIRONMENTAL FACTOR; FEMALE; FRMD3 GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LIMK2 GENE; MAJOR CLINICAL STUDY; MALE; MYH9 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PLESIOMORPHY; POPULATION RESEARCH; RPS12 GENE; SFI1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRPC6 GENE;

AFRICAN AMERICANS; AGED; APOLIPOPROTEINS; DIABETIC NEPHROPATHIES; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84895826536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088273     Document Type: Article

References (24)

1. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, et al. (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305: 2532-2539.
2. System URD (2010) USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: US Renal Data System.
3. Palmer ND, Freedman BI (2012) Insights into the genetic architecture of diabetic nephropathy. Curr Diab Rep 12: 423-431.
4. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845.
5. McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, et al. (2011) A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 79: 563-572.
6. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. (Pubitemid 38579764)
7. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
8. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184.
9. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, et al. (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137.
10. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, et al. (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183. (Pubitemid 35366173)
11. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, et al. (2007) Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 56: 1577-1585. (Pubitemid 46842614)
12. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, et al. (2004) A genome scan for diabetic nephropathy in African Americans. Kidney Int 66: 1517-1526. (Pubitemid 39298385)
13. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, et al. (2005) Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54: 2320-2327. (Pubitemid 41134258)
14. Crowley SD, Coffman TM (2012) Recent advances involving the renin-angiotensin system. Exp Cell Res 318: 1049-1056.
15. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, et al. (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58: 1403-1410.
16. Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, et al. (2012) A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 7: e29202.
17. Tang H, Peng J, Wang P, Risch NJ (2005) Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol 28: 289-301. (Pubitemid 40559542)
18. Keene KL, Mychaleckyj JC, Leak TS, Smith SG, Perlegas PS, et al. (2008) Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet 124: 147-154.
19. Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, et al. (2004) Methods for high-density admixture mapping of disease genes. Am J Hum Genet 74: 979-1000. (Pubitemid 38578397)
20. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204-210. (Pubitemid 351171405)
21. Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, et al. (2011) Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet 7: e1002150.
22. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95: 221-227. (Pubitemid 43093236)
23. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213. (Pubitemid 43177235)
24. System USRD (2013) USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.